Literature DB >> 22389049

A novel combined radiological method for evaluation of the response to chemotherapy for primary bone sarcoma.

Shinji Miwa1, Junichi Taki, Norio Yamamoto, Toshiharu Shirai, Hideji Nishida, Katsuhiro Hayashi, Yoshikazu Tanzawa, Hiroaki Kimura, Akihiko Takeuchi, Kentaro Igarashi, Akishi Ooi, Hiroyuki Tsuchiya.   

Abstract

BACKGROUND: In the treatment of bone sarcoma, evaluation of chemotherapeutic effects is extremely important. In this study, we compared radiological evaluations and histological response, and developed a combined radiological scoring system for assessing the response to chemotherapy.
METHODS: A total of 79 patients with primary bone sarcomas were examined by X-ray photography (Xp), angiography, MRI, 201Tl scintigraphy (Tl) and 99mTc-MIBI scintigraphy (MIBI) to evaluate their response to preoperative chemotherapy. Patients were classified as responders and non-responders according to radiological images. All resected tumors were evaluated histologically and classified as a good response (≥90% necrosis) or a poor response (≤90% necrosis). The sensitivity, specificity, accuracy, and kappa values in radiological evaluation were calculated. Furthermore, we developed a combined radiological scoring system that correlated the results of radiological images with histological response.
RESULTS: Sensitivity, specificity, and accuracy were 90.9%, 38.2%, and 67.5% (K = 0.31), respectively, for Xp; 91.7%, 33.3%, and 66.7% (K = 0.27) for angiography; 81.0%, 67.6%, and 75.0% (K = 0.49) for MRI; 78.9%, 72.4%, and 76.1% (K = 0.51) for Tl; 85.3%, 69.2%, and 78.3% (K = 0.55) for MIBI; and 93.3%, 76.5%, and 86.1% (K = 0.71) for combined radiological scoring.
CONCLUSIONS: Combined radiological evaluations showed high correlation with histological response for assessing the effects of chemotherapy.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22389049     DOI: 10.1002/jso.23074

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Reducing the small-heart effect in pediatric gated myocardial perfusion single-photon emission computed tomography.

Authors:  Hiroto Yoneyama; Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Masahisa Onoguchi; Seigo Kinuya; Lars Edenbrandt
Journal:  J Nucl Cardiol       Date:  2016-05-19       Impact factor: 5.952

2.  Novel Scoring Criteria for Preoperative Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma.

Authors:  Mustafa Hashimi; Obada Hasan; Qiang An; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2021-12

3.  Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.

Authors:  Yogi Prabowo; Iwan Setiawan; Achmad Fauzi Kamal; Evelina Kodrat; Muhammad Luqman Labib Zufar
Journal:  Int J Surg Oncol       Date:  2021-04-26

4.  Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.

Authors:  Shinji Miwa; Akihiko Takeuchi; Toshiharu Shirai; Junichi Taki; Norio Yamamoto; Hideji Nishida; Katsuhiro Hayashi; Yoshikazu Tanzawa; Hiroaki Kimura; Kentaro Igarashi; Akishi Ooi; Hiroyuki Tsuchiya
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

5.  Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft.

Authors:  Shinji Miwa; Akihiko Takeuchi; Hiroko Ikeda; Toshiharu Shirai; Norio Yamamoto; Hideji Nishida; Katsuhiro Hayashi; Yoshikazu Tanzawa; Hiroaki Kimura; Kentaro Igarashi; Hiroyuki Tsuchiya
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

6.  Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?

Authors:  Anna Maria Frezza; Tim Beale; Jamshed Bomanji; Amrita Jay; Nicholas Kalavrezos; Palma Dileo; Jeremy Whelan; Sandra J Strauss
Journal:  BMC Cancer       Date:  2014-01-15       Impact factor: 4.430

7.  Prediction and evaluation of neoadjuvant chemotherapy using the dual mechanisms of 99mTc-MIBI scintigraphy in patients with osteosarcoma.

Authors:  Caixia Wu; Qian Wang; Yuan Li
Journal:  J Bone Oncol       Date:  2019-07-09       Impact factor: 4.072

8.  Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model.

Authors:  Elisa Martella; Barbara Dozza; Claudia Ferroni; Clement Osuru Obeyok; Andrea Guerrini; Daniele Tedesco; Ilse Manet; Giovanna Sotgiu; Marta Columbaro; Marco Ballestri; Lucia Martini; Milena Fini; Enrico Lucarelli; Greta Varchi; Serena Duchi
Journal:  Pharmaceutics       Date:  2022-03-19       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.